乳房假体相关间变性大细胞淋巴瘤风险:3546例长期前瞻性队列
该前瞻性队列纳入1992至2017年单术者使用粗纹理乳房假体行乳房再造的3546例患者,中位随访8.1年,10例发生BIA-ALCL,总体风险为1/355例或0.311例/1000人年(95%CI 0.118-0.503)。研究提示粗纹理假体BIA-ALCL发生率可能高于既往报告,可辅助假体选择决策。
要点
- 粗纹理乳房假体BIA-ALCL总体风险为1/355例或0.311例/1000人年。
- 发生ALCL者中位假体暴露时间为11.5年(范围7.4-15.8年)。
- 该前瞻性长期随访队列提示BIA-ALCL发生率可能高于既往报告。
核心结论
- 粗纹理乳房假体BIA-ALCL发生率可能高于既往报告,结果可辅助乳房再造患者的假体选择。
研究设计与样本
- 中位随访8.1年(范围3个月至30.9年),通过临床、病理及外部记录交叉核对识别BIA-ALCL病例。
主要发现
- 10例女性在假体中位暴露11.5年(范围7.4-15.8年)后发生ALCL。
- 总体BIA-ALCL风险为1/355例或0.311例/1000人年(95%CI 0.118-0.503)。
临床怎么用
- 对使用粗纹理乳房假体行乳房再造的患者,应告知BIA-ALCL风险并坚持长期随访。
- 假体选择时应将BIA-ALCL风险纳入决策考量。
局限性
- 单术者、单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The risk of BIA-ALCL for patients with textured breast implants has been estimated between 1/2832 and 1/30,000 women. Existing studies estimating the numbers exposed and at risk, may have under reported cases, and/or lacked comprehensive follow-up. Our objective is to determine the risk of BIA-ALCL in a defined cohort of patients reconstructed with macro-textured breast implants and consistently followed long-term. METHODS: A prospective cohort study was conducted in patients who underwent breast reconstruction by a single surgeon at Memorial Sloan Kettering Cancer Center (MSKCC) from December 1992 to December 2017. Major events related to implants were prospectively recorded. We identified cases of BIA-ALCL by cross-checking clinical, pathology and external records data. Patients were followed until lymphoma occurrence or last follow-up. The primary outcomes were incidence rate per person-years and cumulative incidence. RESULTS: From 1992 to 2017, 3546 patients underwent 6023 breast reconstructions, mainly after breast cancer removal, or contralateral prophylactic mastectomy, using macro-textured surface expanders and implants. All reconstructions were performed by a single surgeon (PGC). Median follow-up was 8.1 years (range, 3 months - 30.9 years). Ten women, 1/354, developed ALCL after a median exposure of 11.5 years (range, 7.4-15.8 years). Overall risk of BIA-ALCL in our cohort is 1/355 women or 0.311 cases per 1000 person-years (95% CI 0.118 to 0.503). DISCUSSION: This study, the first to evaluate the risk of macro-textured breast implants from a prospective database with long term follow-up, demonstrates that the incidence rate of BIA-ALCL may be higher than previously reported. These results can help inform implant choice for women undergoing breast reconstruction.
引用
- Cordeiro PG, Ghione P, Ni A, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020. PMID: 32008941. doi:10.1016/j.bjps.2019.11.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。